| Therapeutic application of Carica papaya leaf extract in the management of human diseases SP Singh, S Kumar, SV Mathan, MS Tomar, RK Singh, PK Verma, ... DARU Journal of Pharmaceutical Sciences 28, 735-744, 2020 | 132 | 2020 |
| Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells SP Singh, A Mishra, RK Shyanti, RP Singh, A Acharya Biological Trace Element Research 199, 1316-1331, 2021 | 86 | 2021 |
| Protein kinase C-α and the regulation of diverse cell responses RK Singh, S Kumar, PK Gautam, MS Tomar, PK Verma, SP Singh, ... Biomolecular concepts 8 (3-4), 143-153, 2017 | 75 | 2017 |
| NK cell effector functions regulation by modulating nTreg cell population during progressive growth of Dalton’s lymphoma in mice MS Tomar, S Kumar, S Kumar, PK Gautam, RK Singh, PK Verma, ... Immunological investigations 47 (1), 40-56, 2018 | 15 | 2018 |
| Anticancer effects and associated molecular changes of Carica papaya against prostate cancer SP Singh, SV Mathan, A Dheeraj, D Tailor, RP Singh, A Acharya Cancer Research 79 (13_Supplement), 3004-3004, 2019 | 10 | 2019 |
| Anticancer Attributes of silibinin: chemo-and radiosensitization of cancer A Dheeraj, D Tailor, SP Singh, RP Singh Role of nutraceuticals in cancer chemosensitization, 199-220, 2018 | 9 | 2018 |
| Classical Protein Kinase C: a novel kinase target in breast cancer RK Singh, S Kumar, MS Tomar, PK Verma, SP Singh, PK Gautam, ... Clinical and Translational Oncology 21, 259-267, 2019 | 7 | 2019 |
| Aqueous extract of Carica papaya leaf elicits the production of TNF-α and modulates the expression of cell surface receptors in tumor-associated macrophages SP Singh, S Kumar, MS Tomar, RK Singh, PK Verma, A Kumar, S Kumar, ... Biosc Biotech Res 4, 1115-1122, 2019 | 5 | 2019 |
| Recent advancement in the development of anti-cancer drugs PK Verma, S Kumar, MS Tomar, RK Singh, SP Singh, A Acharya Int. J. Recent Sci. Res 9, 26846-26849, 2018 | 2 | 2018 |
| Decursin inhibits EGFR‐ERK1/2 signaling axis in advanced human prostate carcinoma cells TA Bhat, A Dheeraj, DK Nambiar, SP Singh, DS Yim, RP Singh The Prostate, 2023 | 1 | 2023 |
| PKCα: regulation and implication for cellular transformation RK Singh, S Kumar, MS Tomar MOJ Tumor Res 1 (2), 44-47, 2018 | 1 | 2018 |
| Andrographolide Induces G2/M Phase Cell Cycle Arrest in Human Head and Neck Cancer Cells AB Kartha, DM Tailor, SP Singh, RK Kale, RP Singh Int. j. biotech. biomed. sci 2 (3), 271-278, 2016 | 1 | 2016 |
| TRIP13 is a promising therapeutic target for bladder cancer SP Singh, K Goswami, AS Asch, CV Rao, V Madka Cancer Research 84 (6_Supplement), 506-506, 2024 | | 2024 |
| Preventing CRC progression in FAP rat model using a combinational targeting of TRAIL signaling and inflammation V Madka, G Pathuri, K Venkatachalam, SP Singh, A Singh, N Stratton, ... Cancer Research 84 (6_Supplement), 7299-7299, 2024 | | 2024 |
| Effect of estrogen receptor modulator bazedoxifene on progression of carcinogen induced bladder cancer in female F344 rats V Madka, G Pathuri, SP Singh, S Chiliveru, A Singh, A Bao, N Stratton, ... Cancer Research 84 (6_Supplement), 7302-7302, 2024 | | 2024 |
| Bladder Cancer Prevention: Potential Molecular Targets and Their Clinically Relevant Agents SP Singh, AS Asch, CV Rao, V Madka Current Pharmacology Reports 9 (5), 275-283, 2023 | | 2023 |
| Chemopreventive efficacy of everolimus and naproxen combination against carcinogen induced bladder cancer in F344 rats V Madka, G Pathuri, SP Singh, A Singh, A Bao, N Stratton, S Lightfoot, ... Cancer Research 83 (7_Supplement), 5260-5260, 2023 | | 2023 |
| Effect of STAT3 inhibitors, TTI-101 and SH5-07, against bladder cancer in preclinical 3D tumor models SP Singh, G Pathuri, A Asch, B Cholewa, R Shoemaker, CV Rao, ... Cancer Research 83 (7_Supplement), 5255-5255, 2023 | | 2023 |
| Abstract A018: Targeting STAT3 for bladder cancer prevention – in vitro studies using spheroid and organoid models SP Singh, G Pathuri, A Asch, B Cholewa, R Shoemaker, CV Rao, ... Cancer Prevention Research 15 (12_Supplement_2), A018-A018, 2022 | | 2022 |
| Developing a Non-Immunogenic and Biocompatible Polymeric Self-Assembly By Using RAFT Methodology for Therapeutics Application A Kumar, A Anand, RK Singh, PK Verma, S Pratap, SK Singh, A Acharya Journal of Scientific Research 64 (1), 2020 | | 2020 |
Arbind AcharyaBanaras Hindu UniversityBestätigte E-Mail-Adresse bei bhu.ac.in
